Search - tctmd.com

Displaying 61 - 80 of 231

Sort: Relevancy | Date

News Daily News

MR Improves in Half of Low-Flow/Low-Gradient AS Patients Undergoing TAVR

Michael O'Riordan

February 13, 2020

News Daily News

ACS After TAVR a Unique Condition With Poor Prognosis

Todd Neale

February 05, 2020

News Daily News

TAVR and Other Advanced CVD Therapies Used Less in Ontario Than NY State

Michael O'Riordan

January 22, 2020

News Daily News

Optimal Implantation Depth With Self-Expanding TAVR? Success May Prove Elusive

Yael L. Maxwell

December 19, 2019

News Daily News

Diastolic Dysfunction Does Not Negate Health Status Benefits of TAVR

Todd Neale

November 27, 2019

Pulmonary Hypertension, Common in TAVR Patients, Linked to Lower Survival

Michael O'Riordan

November 26, 2019

Presentation TCT Abstracts Posters 2019

Acute Changes in Left Ventricular Cardiac Mechanics Post Transcatheter Aortic Valve Replacement by Speckle Tracking Echocardiography

Presenter: Stamatios Lerakis

October 20, 2019

News Conference News TCT 2019

Portico Noninferior to Commercial TAVR Valves in IDE Study

Caitlin E. Cox

September 27, 2019

News Daily News

Surgical Bailout Rarely Needed Though Can Save Lives: TVT Registry

Yael L. Maxwell

September 18, 2019

News Daily News

MIDAS Touch: Anatomic Strategy Dramatically Lowers Pacemaker Rate With Evolut Valves

Michael O'Riordan

August 29, 2019

News Daily News

FDA Expands TAVR Indication to Low-Risk Patients

Michael O'Riordan

August 16, 2019

News Daily News

Elevated BP Linked to Risk of Valvular Heart Disease, Including Aortic Stenosis

Michael O'Riordan

July 12, 2019

News Daily News

Life Expectancy Post-SAVR Varies by Age, Raising Questions for Treatment Timing

Caitlin E. Cox

July 01, 2019

News Industry News

Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation

June 24, 2019

News Conference News EuroPCR 2019

Longer Follow-up ‘Reassuring’ for New-Onset LBBB After TAVR—With Caveats

Michael O'Riordan

May 22, 2019

News Daily News

FDA Approves Lotus Edge, Ushering Third Device Into US Market

Shelley Wood

April 24, 2019

News Daily News

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

L.A. McKeown

April 19, 2019

News Daily News

HF Admissions Decline, Non-CV Hospitalizations Rise After TAVR

L.A. McKeown

March 13, 2019

News Daily News

Aortic Stenosis Staging System Validated in Real-World, All-Comers Cohort

L.A. McKeown

February 14, 2019

News Daily News

Half of TAVR Patients Develop Potentially Dangerous Conduction Abnormalities

Yael L. Maxwell

January 11, 2019

Advertisement

MR Improves in Half of Low-Flow/Low-Gradient AS Patients Undergoing TAVR

ACS After TAVR a Unique Condition With Poor Prognosis

TAVR and Other Advanced CVD Therapies Used Less in Ontario Than NY State

Optimal Implantation Depth With Self-Expanding TAVR? Success May Prove Elusive

Diastolic Dysfunction Does Not Negate Health Status Benefits of TAVR

Pulmonary Hypertension, Common in TAVR Patients, Linked to Lower Survival

Acute Changes in Left Ventricular Cardiac Mechanics Post Transcatheter Aortic Valve Replacement by Speckle Tracking Echocardiography

Portico Noninferior to Commercial TAVR Valves in IDE Study

Surgical Bailout Rarely Needed Though Can Save Lives: TVT Registry

MIDAS Touch: Anatomic Strategy Dramatically Lowers Pacemaker Rate With Evolut Valves

FDA Expands TAVR Indication to Low-Risk Patients

Elevated BP Linked to Risk of Valvular Heart Disease, Including Aortic Stenosis

Life Expectancy Post-SAVR Varies by Age, Raising Questions for Treatment Timing

Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation

Longer Follow-up ‘Reassuring’ for New-Onset LBBB After TAVR—With Caveats

FDA Approves Lotus Edge, Ushering Third Device Into US Market

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

HF Admissions Decline, Non-CV Hospitalizations Rise After TAVR

Aortic Stenosis Staging System Validated in Real-World, All-Comers Cohort

Half of TAVR Patients Develop Potentially Dangerous Conduction Abnormalities

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content